Science Codex | Mesoblast limited : MPCs Strengthen Cardiac Function in End-Stage Heart Failure 4-traders (press release) The researchers reported that a single injection into the native heart of 25 million allogeneic, or "off-the-shelf", MPCs resulted in an improvement in cardiac function at the pre-specified key efficacy endpoint of 90 days, as measured by the ability ... Heart failure patients receiving LVAD may benefit from injection of powerful ... Mesoblast MPCs improve function in heart failure Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With ... |
